Top Stories

Published on Tuesday, February 26, 2019

The Alpha-1 Foundation gears up for the 2019 Global meetings in Dubrovnik, Croatia

The Alpha-1 Foundation gears up for the 2019 Global meetings in Dubrovnik, Croatia

MIAMI, Feb. 26th, 2019 - The 7th Alpha-1 Global Patient Congress and 4th International Research Conference on Alpha-1 Antitrypsin will be held April 3-6, at the Sheraton Dubrovnik Riviera Hotel in Dubrovnik, Croatia. Patient leaders, physicians and scientists from around the world will come together to discuss the latest developments in patient advocacy, clinical care and Alpha-1 Antitrypsin Deficiency (Alpha-1) research. 

With a rich history of international collaboration, the Foundation is committed to Alphas worldwide and is proud to host representatives from 32 countries. Through the dedication of the Conference Planning Committee, we are looking forward to another outstanding event. The commitment to the mission drives the Alpha-1 Global program each day, to increase awareness, detection, and access to care for Alphas around the world.  

“The recent changes in the Alpha-1 Global program offers me the opportunity to reshape our outreach to the entire Alpha-1 community, globally. Our strategic alliances are strong and will be reaffirmed in Dubrovnik, Croatia, at our International Scientific Conference and concurrent International Patient Congress. I would like to extend my gratitude to the Internal Conference Planning Committee, Richard Lovrich, who will be our emcee, and the Foundation’s hardworking staff and volunteers,” expressed Miriam O’Day, president and CEO of the Alpha-1 Foundation.

“These events will be the first international meetings I have attended since our meeting in Barcelona, in 2013. This is an exciting opportunity to be able to collaborate and strategize about the future of the Global program in my new role as president and CEO,” she added.

The 2019 meeting will begin with the 4th International Research Conference on Wednesday and Thursday, April 3-4. The Research Conference theme titled “Beyond Folding: Disease Progression and Therapeutic Options” is chaired by Professor Rob Stockley from University Hospitals Birmingham, United Kingdom. 

The program agenda for the 4th International Research Conference is available to view here

We will continue with representatives from 32 countries at the Global Patient Congress with a welcome reception and networking dinner where Alpha-1 patients, physicians and researchers can interact on Thursday, April 4th. The patient congress will continue Friday and Saturday, April 5-6.

The program agenda for the 7th Alpha-1 Global Patient Congress is available to view here

A special thank you to our outstanding Global Conference Planning Committee and Global Advisory Committee:

  • Cristina Barbiero, National Association Alfa-1 AT Italy, EU Advocacy Working Group, Italy
  • Jim Clarke, Alpha-1 Association New Zealand Co-Leader Alpha-1 Support Group, New Zealand
  • Shane Fitch, Lovexair Foundation - President, Spain
  • Elena Goyanes, Alpha-1 Association Spain, EU Advocacy Working Group, Spain
  • Karen O'Hara, Alpha-1 UK Support Group - ERN - Lung, EARCO, UK
  • Carlos Cambon, Alpha-1 Association Argentina, Argentina  
  • Martina Cambon, Alpha-1 Association Argentina, Argentina
  • Frank Willersinn, MD, Alpha-1 Plus, Belgium
  • Marion Bouchecareilh, University of Bordeaux, Alpha-1 Liver Research, France
  • Robert Durlik, Alpha-1 Poland, Founder, Poland
  • Robert Kroesen, Patient Representative, Panama
  • Tim Frost, AlphaNet Board Member, USA

Global Advisory Committee: 

  • Jeanine D’Armiento, MD, PhD, Alpha-1 Foundation – Chair, USA
  • Robert Sandhaus, MD, PhD, FCCP, Alpha-1 Foundation Medical Director, USA
  • Robert Stockley, MD, Director Lung Immuno Biochemical Research Laboratory, UK
  • Adam Wanner, MD, Alpha-1 Foundation Scientific Director, USA

The Alpha-1 Foundation graciously thanks the 2019 Alpha-1 Global Patient Congress and Research Conference Sponsors. Presenting Sponsors: AlphaNet, CSL Behring and Grifols. Gold Sponsors: Arrowhead, Kamada and Vertex. Bronze Sponsors: Dicerna and Mereo BioPharma.


For additional information on the upcoming events, please contact Randel Plant, global programs manager, or 877-228-7321 ext. 306.

For hotel and travel arrangements, please contact Adriana De Arce, manager of scientific events, or 877-228-7321 ext. 269.


Kathy Haduck receives Helen Chase Walsh Memorial Award

Thursday, June 17, 2010
AlphaNet Coordinator Kathy Haduck of Blandburg, PA, was honored with the Helen Chase Walsh Memorial Award at the recent annual education conference of the Alpha-1 Association in Orlando, FL. The award is presented each year by the Walsh family to...

Do you have the scoop on Alpha-1?

Thursday, June 17, 2010
Darin and Megan Chittick know exactly why it’s important to support Alpha-1 fundraisers. Their daughter, McKinley Chittick, who is now three years old, was diagnosed with Alpha-1 when she was just a month old. She developed severe jaundice...

$1 million donation by Cadwgans to help Alpha-1 Foundation "find new therapies and ultimately, a cure"

Wednesday, June 16, 2010
Ruth and Gordon E. Cadwgan, Jr., made a surprise announcement at this past weekend’s national education conference in Orlando: the donation of a million dollars to the Alpha-1 Foundation from themselves and Gordon Cadwgan, Sr. Gordon...

Foundation scientific director receives "outstanding investigator" award from Hungarian Respiratory Society

Wednesday, June 16, 2010
SOPRON, HUNGARY—Alpha-1 Foundation Scientific Director Adam Wanner, MD, recently received the “Outstanding Investigator Award” from the Hungarian Respiratory Society at its biennial meeting. Wanner gave the keynote speech at the...

Foundation presents Building Friends for a Cure awards

Monday, June 14, 2010
ORLANDO, FL—The Alpha-1 Foundation presented its Building Friends for a Cure awards Friday evening during the Alpha-1 Association’s annual educational conference. The Alpha-1 Foundation presented awards to the following. All-Star...

Alpha-1 protein to be tested as treatment for Type 1 diabetes

Wednesday, June 9, 2010
MarketWire DENVER, CO—Omni Bio Pharmaceutical, Inc. announced that the Barbara Davis Center for Childhood Diabetes has received regulatory clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase I and II clinical...

Childhood liver disease studies enrolling patients; some travel funds available to eligible families

Tuesday, June 8, 2010
The Childhood Liver Disease Research and Education Network (ChiLDREN) is enrolling children now for vital research studies on cholestatic liver diseases of children. In cholestatic liver disease, the flow of bile from the liver into the digestive...

Grifols, Talecris press release on planned acquisition

Monday, June 7, 2010
PR Newswire BARCELONA, Spain and RESEARCH TRIANGLE PARK, NC—Grifols a global healthcare company and leading producer of plasma protein therapies, and Talecris, a US-based biotherapeutics products company, today announced that they have...

Spanish company Grifols to acquire Talecris for $3.4 billion

Monday, June 7, 2010
Reuters Spain’s Grifols has agreed to buy US-based Talecris Biotherapeutics, which makes plasma-based protein therapies, for $3.4 billion in a bold move to expand its business in blood products. Talecris is the manufacturer of Prolastin,...

Marta Strock dies; one of first AlphaNet coordinators

Monday, June 7, 2010
Marta Strock was one of the first AlphaNet coordinators, and proud of it. “As an AlphaNet coordinator,” she told a magazine writer in 2004, “I have the opportunity to bring a wealth of knowledge about our disease to many Alphas...

Anti-seizure drug improves liver disease in Alpha-1 mice

Friday, June 4, 2010
A note from Robert A. Sandhaus, MD, PhD, clinical director of the Alpha-1 Foundation and medical director of AlphaNet: In the interest of presenting the latest information to our Alpha-1 community, the following press release has been posted...

Whom to test, whom to treat, for Alpha-1?

Friday, June 4, 2010
An examination of the current issues in testing and treating for Alpha-1 has been published by Robert A. Sandhaus, MD, PhD, in the journal Seminars in Respiratory and Critical Care Medicine. Sandhaus is clinical director of the Alpha-1...

Article Search

Enter keywords in text box and click Search button for results.